Trial Profile
A phase II study of sNN0029 in patients with Amyotrophic Lateral Sclerosis (ALS)
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 05 Aug 2015
Price :
$35
*
At a glance
- Drugs SNN 0029 (Primary)
- Indications Amyotrophic lateral sclerosis
- Focus Therapeutic Use
- 05 Aug 2015 New trial record